Kompositt Biomarkører

Post-HSCT Overvåkning - 28.0 måneder
Generated 2026-03-24 00:23 · Post-HSCT Patient
ADSI
74.7/100
Autonomic Dysfunction | Trend: stabil
GVHD Score
21.7/100
Wearable Activity | Trend: forverring
Recovery
66.2/100
Trajectory Index | Trend: bedring
Pharma
0.8Z
Ruxolitinib Response | Trend: stabil
CV Risk
63.4/100
Cardiovascular Composite | Trend: stabil
Allostatic
2.3/7
Load Score | Trend: stabil

Sammendrag

Post-HSCT Patient | 28.0 måneder post-HSCT | Ruxolitinib fra 2026-03-16

BiomarkørVerdiTrend
ADSI74.7/100stabil
GVHD_SCORE21.7/100forverring
RECOVERY_INDEX66.2/100bedring
CV_RISK63.4/100stabil
ALLOSTATIC_LOAD2.3/7stabil

Biomarkør-Dashboard

Oura Digital Twin · Wearable Biometric Analysis · Generated 2026-03-24 00:23